Can a pregnancy hormone influence cardiovascular therapy — STAT News
In STAT News, the biotechnology newsletter The Readout raised the question of whether a pregnancy hormone can influence the development of a cardiovascular therapy. The publication is dated August 31, 2026.
Radiopharmaceuticals and mRNA
The author of the article is biotechnology correspondent Meghana Keshavan, who also works on The Readout. The brief preview states that researchers in radiopharmaceuticals are taking bolder approaches to dosing.
More current news is available on the UA.News Telegram channel Telegram.
The preview also says that cancer vaccines may help restore the reputation of mRNA technologies. The publication’s subheading separately mentions skepticism about mRNA.
Topics of the publication
STAT News tagged the text with biotechnology, drug development, drug prices, and research. The preview also describes the issue as a roundup of other biotechnology industry news. It does not specify which hormone, therapy method, or research results are being discussed.
